{"created":"2025-02-23T06:29:56.363976+00:00","id":2013320,"links":{},"metadata":{"_buckets":{"deposit":"4eda3ab2-0242-45b4-ad69-2a964782888f"},"_deposit":{"created_by":41,"id":"2013320","owners":[41],"pid":{"revision_id":0,"type":"depid","value":"2013320"},"status":"published"},"_oai":{"id":"oai:hiroshima.repo.nii.ac.jp:02013320","sets":["1727147343679:1730442224523:1730442317341"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"BCR-ABL mRNA Expression in Patients with Chronic Myeloproliferative Disorders : Absence of BCR-ABL Fused Clone except Chronic Myelocytic Leukemia","subitem_title_language":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Nakata, Yoshio","creatorNameLang":"en"}],"familyNames":[{"familyName":"Nakata","familyNameLang":"en"}],"givenNames":[{"givenName":"Yoshio","givenNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_subject":"Breakpoint cluster region","subitem_subject_scheme":"Other"},{"subitem_subject":"c-Abl","subitem_subject_scheme":"Other"},{"subitem_subject":"Chronic myeloproliferative disorders","subitem_subject_scheme":"Other"},{"subitem_subject":"490","subitem_subject_scheme":"NDC"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"Bcr-abl mRNA expression was studied in patients with chronic myeloproliferative disorders (CMPD) by the reverse transcriptase-polymerase chain reaction (RT-PCR) method. A bcr-abl transcript was not found in any patient with polycythemia vera, essential thrombocythemia or primary myelofibrosis, suggesting that the bcr-abl rearranged clone is not present in CMPD other than chronic myelogenous leukemia (CML). In CML clinical and laboratory data were compared from three bcr-abl types: the bcr exon 2-abl exon 2 (B2-A2) type, bcr exon 3-abl exon 2 (B3-A2) type and the co-expression type. Age at diagnosis tended to be younger (p=0.08) in the co-expression type, and the platelet count tended to be lower (p=0.11) in the B2-A2 type. However, there was no difference in other data, including the duration of the chronic phase and the phenotype of blasts at blast crisis.","subitem_description_language":"en"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_publisher":"Hiroshima University Medical Press"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617186920753":{"attribute_name":"Source Identifier","attribute_value_mlt":[{"subitem_source_identifier":"0018-2052","subitem_source_identifier_type":"ISSN"},{"subitem_source_identifier":"AA00664312","subitem_source_identifier_type":"NCID"}]},"item_1617187024783":{"attribute_name":"開始ページ","attribute_value_mlt":[{"subitem_start_page":"67"}]},"item_1617187056579":{"attribute_name":"bibliographic_information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1993-06","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"71","bibliographicPageStart":"67","bibliographicVolumeNumber":"42","bibliographic_titles":[{"bibliographic_title":"Hiroshima Journal of Medical Sciences"},{"bibliographic_title":"Hiroshima Journal of Medical Sciences"}]}]},"item_1617258105262":{"attribute_name":"item_1617258105262","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"HiroshimaJMedSci_42_67.pdf","filesize":[{"value":"561.6 KB"}],"mimetype":"application/pdf","url":{"objectType":"fulltext","url":"https://hiroshima.repo.nii.ac.jp/record/2013320/files/HiroshimaJMedSci_42_67.pdf"},"version_id":"1dae059a-5ec2-46db-b044-8f03a573b5d7"}]},"item_1732771732025":{"attribute_name":"旧ID","attribute_value":"37917"},"item_title":"BCR-ABL mRNA Expression in Patients with Chronic Myeloproliferative Disorders : Absence of BCR-ABL Fused Clone except Chronic Myelocytic Leukemia","item_type_id":"40003","owner":"41","path":["1730442317341"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-03-18"},"publish_date":"2023-03-18","publish_status":"0","recid":"2013320","relation_version_is_last":true,"title":["BCR-ABL mRNA Expression in Patients with Chronic Myeloproliferative Disorders : Absence of BCR-ABL Fused Clone except Chronic Myelocytic Leukemia"],"weko_creator_id":"41","weko_shared_id":-1},"updated":"2025-06-02T03:05:00.544216+00:00"}